Stock Spotlight: EBOS Group Ltd (ASX:EBO)

About EBOS Group Ltd

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.



Key Stats

Source: Yahoo Finance. Data as of 05/09/25.

Price Performance

Growth Potential

  • Recent share price correction has resulted in EBO’s valuation looking more attractive along with offering a solid dividend yield.
  • While EBO earnings are not completely immune to economic conditions, we do believe there are elements of defensive quality to EBO’s earnings which may warrant a premium to the market.
  • Leveraged to positive industry trends across healthcare (ageing population + increased pharma & medical spend) and increased pet spend (pet ownership + pert humanization).
  • Market leading positions including - pharmaceutical wholesaler (Aus & NZ), community pharmacy network in Australia (TerryWhite Chemmart), ANZ/NZ hospital medicines wholesaler and ANZ’s largest dry dog food brand in pet specialty
  • Bolt on acquisitions to supplement organic growth – the Company has a successful history of making acquisitions.
  • New contract wins.


Key Risks

  • Changes to the industry structure or competitive landscape which leads to increased customer churn (loss of contracts).
  • Poor execution.
  • Value destructive M&A.
  • Change in senior management.
  • Cut to dividends due to balance sheet or earnings pressure.

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Speak to an Advisor

RBA’s Fifth Rate Hike of 2026: Reading the ASX Signals

November 4, 2026
The RBA lifted the cash rate to 4.85% in a split vote. Here’s how higher rates flow through ASX sectors, company earnings, dividends and valuations.

Inside Anthropic’s IPO Filing: Rapid Growth, Rising Stakes

October 29, 2026
Inside Anthropic’s IPO filing: explore its soaring revenue, computing commitments, reported losses and governance structure, and what the disclosures mean for investors.

How to Read Big Tech Earnings: What to Look for Beyond Revenue Growth

October 21, 2026
Big Tech reports next week. Learn how to read earnings releases and filings, and what to look for in AI spending, cloud growth, cash flow and guidance.

Is the AI Boom Becoming a Financial Stability Risk?

October 14, 2026
Understand how AI investment could affect global financial stability, as the IMF and RBA warn of rising debt, market concentration and funding risks.

Firmus and the Price of AI Infrastructure: Is Australia Ready for an AI Mega-IPO?

October 8, 2026
Firmus’ proposed mega-IPO puts a spotlight on the cost, capital intensity and risks of building AI infrastructure as investors weigh the next phase of the AI boom.

Stock Spotlight: Electro Optic Systems Holdings Ltd (ASX:EOS)

October 6, 2026
About Electro Optic Systems Holdings Ltd. Electro Optic Systems Holdings Limited engages in the development, manufacture, and sale of telescopes and dome enclosures, laser satellite tracking systems, remote weapon systems, and high laser weapon. It operates through Defense Systems and Space Systems segments. The company develops, manufactures, and markets fire control, surveillance, weapon systems, and high energy laser to military customers. It also provides passive optical and laser sensing equipment; optical, microwave and on-the-move radio and satellite products; and laser-based surveillance systems with space tracking capability. In addition, the company offers counter-drone, firepower, force protection, and UGV and marine lethality systems, as well as high energy laser weapon; optical tracking systems, space control, space domain awareness, satellite laser ranging, space sustainability, and precision optics. It operates in Australia, the United States, Singapore, the United Arab Emirates, the United Kingdom, New Zealand, the Netherlands, North America, Germany, and rest of Europe. Electro Optic Systems Holdings Limited was founded in 1983 and is based in Symonston, Australia. Source: EODHD Key Stats

Stock Spotlight: Liontown Ltd (ASX:LTR)

October 6, 2026
About Liontown Ltd. Liontown Limited engages in the exploration, evaluation, and development of mineral properties in Australia. It primarily explores for lithium, gold, and nickel deposits. The company's flagship property is the Kathleen Valley lithium project located in Perth, Western Australia. The company was formerly known as Liontown Resources Limited and change its name to Liontown Limited in November 2025. Liontown Limited was incorporated in 2006 and is headquartered in West Perth, Australia. Source: EODHD Key Stats

The RBA Hikes to 4.60%: A New Inflation Challenge

September 30, 2026
The RBA has raised rates to 4.60% as inflation pressures persist. Explore the impact of energy costs, AI demand and the key signals investors should watch next.

Genomics: Why the Next Wave of Healthcare Innovation Could Be Written in Our DNA

September 22, 2026
Discover how advances in genomics, AI, diagnostics and gene editing are creating a broader healthcare opportunity and where commercial value is emerging.

The AI Trade Just Hit an Uncomfortable Question: What If Progress Slows?

September 15, 2026
The AI trade is being forced to rethink the pace of progress. Here is what investors should watch across Nvidia, chips, AI spending, software and adoption.